Comparing gene expression profiles of Kashin-Beck and Keshan diseases occurring within the same endemic areas of China

Xi Wang1, Shuang Wang1, Shulan He1, Feng Zhang1, Wei Tan1, Yanxia Lei1, Hanjie Yu2, Zheng Li2, Yujie Ning1, Youzhang Xiang3, Xiong Guo1
1Faculty of Public Health, Medical College of Xi’an Jiaotong University, Key Laboratory of Environment and Gene Related Diseases of Ministry of Education, Key Laboratory of Trace Elements and Endemic Diseases of Ministry of Health, Xi’an, 710061, China
2National Engineering Research Center for Miniaturized Detection Systems, Northwest University, Xi’an, 710069, China
3Shandong Institute for Prevention & Treatment of Endemic Disease, Jinan, 250014, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Fang H, Guo X, Farooq U, et al. Development and validation of a quality of life instrument for Kashin-Beck disease: an endemic osteoarthritis in China. Osteoarthr Cartilage, 2012, 20: 630–637

Ministry of Public Health of China. 2012 China Health Statistics Yearbook. Peking Union Medical College, 2012. 57

Duan C, Guo X, Zhang X D, et al. Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease. Arthritis Rheum, 2010, 62: 771–780

Lei C, Niu X, Ma X, et al. Is selenium deficiency really the cause of Keshan disease? Environ Geochem Health, 2011, 33: 183–188

Zou K, Liu G, Wu T, et al. Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthr Cartilage, 2009, 17: 144–151

Burke M P, Opeskin K. Fulminant heart failure due to selenium deficiency cardiomyopathy (Keshan disease). Med Sci Law, 2002, 42: 10–13

Chasseur C, Suetens C, Nolard N, et al. Fungal contamination in barley and Kashin-Beck disease in Tibet. Lancet, 1997, 350: 1074

Sun S. Chronic exposure to cereal mycotoxin likely citreoviridin may be a trigger for Keshan disease mainly through oxidative stress mechanism. Med Hypotheses, 2010, 74: 841–842

Moreno Reyes R, Mathieu F, Boelaert M, et al. Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr, 2003, 78: 137–144

Yang J, Wang T, Wu C, et al. Selenium level surveillance for the year 2007 of Keshan disease in endemic areas and analysis on surveillance results between 2003 and 2007. Biol Trace Elem Res, 2010, 138: 53–59

Wang L H, Fu Y, Shi Y X, et al. T-2 toxin induces degenerative articular changes in rodents: link to Kaschin-Beck disease. Toxicol Pathol, 2011, 39: 502–507

Wang W Z, Guo X, Duan C, et al. Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthr Cartilage, 2009, 17: 83–90

Zhang F, Guo X, Wang W, et al. Genome-wide gene expression analysis suggests an important role of hypoxia in the pathogenesis of endemic osteochondropathy Kashin-Beck disease. PLoS ONE, 2011, 6: e22983

Chang X, Han J, Zhao Y, et al. Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. BMC Musculoskel Dis, 2010, 11: 279

Zheng T L, Cui Y L, Sun J C, et al. Progression in pathology and pathogenesis of Keshan disease (in Chinese). Chin J Endemiol, 1982, 1: 194–195

Peng C X, Gao Y M. Studies of the physiological function of carbonic anhydrase. J Peking Univ (Health Sci), 2007, 39: 210–212

Li L Z, Huang Z X. Progression in cytochrome c oxidase studies. Chinese J Inorg Chem, 2011, 17: 761–762

Liu J T, Guo X, Ma W J, et al. Mitochondrial function is altered in articular chondrocytes of an endemic osteoarthritis, Kashin-Beck disease. Osteoarthr Cartilage, 2010, 18: 1218–1226

Hui Y, Cao Y H, Wang S P, et al. Effect of low-dose citreoviridin on activities of cytochrome c oxidase and succinate dehydrogenase in rat myocardium (in Chinese). Chin J Endemiol, 2007, 26: 627–629

Wu L, Chen J L. Effect of Se deficiency and exercise on the cardiolipin content and cytochrome c oxidase activity of mitochondria in rats’ heart. Chin J Sport Med, 1995, 14: 65–68

Mentlein R. Targeting pleiotropin to treat osteoarthritis. Expert Opin Ther Targets, 2007, 11: 861–867

Tapp H, Hernandez D J, Neame P J, et al. Pleiotrophin inhibits chondrocyte proliferation and stimulates proteoglycan synthesis in mature bovine cartilage. Matrix Biol, 1999, 18: 543–556

Pufe T, Bartscher M, Petersen W, et al. Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthr Cartilage, 2003, 11: 260–264

Meng K, Rodriguez Pena A, Dimitrov T, et al. Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci USA, 2000, 97: 2603–2608

Li J, Wei H, Chesley A, et al. The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity. J Biol Chem, 2007, 282: 34984–34993

Yang F Y, Lin Z H. variation of the erythrocyte membrane in Keshan disease patients. Chin Sci Bull, 1988, 20: 1580–1582

Xu H, Zhang Z H. The effect of different-state hemoglobin on function of erythrocyte membranes. Acta Bioph Sin, 1992, 8: 481–487

Yang F Y. Trace elements and the erythrocyte membrane skeleton in people (in Chinese). Prog Nat Sci, 1993, 3: 481–487

Jin S M, Xu H Y. Significance of the change of hemoglobin level in chronic heart failure patients. China Foreign Med Treatment, 2010, 17: 60–62

Shan X J, Wu R Z. The relationship between serum sICAM-1, hemoglobin level and cardiac function in the patients with chronic heart failure. Mod Pract Med, 2009, 21: 468–480

Wu Y X. The clinical significance of the variation of hemoglobin level in the patients with chronic heart failure. Pract Med, 2011, 27: 621–622

Yang F Y, Lin Z H. Research of the erythrocyte membrane of the children with Kashin-Beck disease in Za Lan Tun. Endemic Commun, 1985, 1: 25–28

Kobayashi M, Squires G R, Mousa A, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum, 2005, 52: 128–135

Tong W S, Yang T F. IL-1 and TNF bioassay in synovial fluid of patients with Kashin-Beck disease. Chin J Endemiol, 2000, 15: 71–72

Shi G Q, Jin R L, Tong Z H. Clinical observation of the level of IL-1 in the osteoarthritis patients. China Pract Med, 2009, 4: 45–46

Wang S, Guo X, Wu X M, et al. Genome-wide gene expression analysis suggests an important role of suppressed immunity in pathogenesis of Kashin-Beck disease. PLoS ONE, 2012, 7: e28439

Yu M, Guo X. Association between polymorphism in DVWA and IL-1 and Kashin Beck disease. J Sichuan Univ (Med sci), 2010, 41: 669–673

Jung M Y, Kang S W, Kim S K, et al. The interleukin-1 family gene polymorphisms in Korean patients with rheumatoid arthritis. Scand J Rheumatol, 2010, 39: 190–196

Bensen J T, Dawson P A, Mychaleckyj J C, et al. Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. J Interferon Cytokine Res, 2001, 21: 899–904

Xu H L, Zhao L Y. Interleukin-1 and cardiovascular disease. Chin Heart J, 2000, 12: 401–402

Gu G S, Che M X. Calcium channel of osteoblast. Chin J Clin Oncol Rehabil, 2009, 9: 120–122

Guggino S E, Wagner J A, Snowman A M, et al. Phenylalkylamine-sensitive calcium channels in osteoblast-like osteosarcoma cells. Characterization by ligand binding and single channel recordings. J Biol Chem, 1988, 263: 10155–10161

Hong K, Liu X. The diseases of cardiac calcium channel. Chin J Cardiac Pacing Electr, 2011, 25: 189–191